Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens.

Current oncology reports

Volumn 2, Issue 2, 2000, Pages 182-191

  Champlin, R ^a   van Besien K, ^a   Giralt, S ^a   Khouri, I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; METHODOLOGY; MORTALITY; NONHODGKIN LYMPHOMA; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL; TREATMENT OUTCOME;

FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA; LYMPHOMA, LOW-GRADE; LYMPHOMA, MANTLE-CELL; MALE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0034156690     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-000-0092-y     Document Type: Review

References (126)